Group comparison based on genetic information reveals lineage-specific therapeutic vulnerabilities in acute myeloid leukemia
J. Nakahara, K. Yamamoto, T. Yabushita, T. Chinen, K. Ito, Y. Takeda, D. Kitagawa, S. Goyama
The paper identifies lineage-specific therapeutic vulnerabilities in AML subtypes using a two-group comparison approach based on genetic data from the Cancer Dependency Map.
bioRxiv · May 18, 2023 · PreprintCancer Biology